HCV NS5A inhibitors (Abbvie)

N/A

Report date: 2025/03/20 15:13:17

NME

Base Information

Drug NameHCV NS5A inhibitors (Abbvie)

Drug Alias NameN/A

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionNonstructural protein 5A inhibitors

TargetsNonstructural protein 5A

Therapy Area/IndicationsHepatitis C

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesAbbvie Inc

China Registration ClassN/A

Active CompaniesAbbvie Inc

Inactive CompaniesN/A

Active IndicationsHepatitis C

Inactive IndicationsN/A

ATC CodeN/A